Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects

Hepatocellular carcinoma (HCC) is the most prevalent primary liver cancer with poor prognosis. Surgery, chemotherapy, and radiofrequency ablation are three conventional therapeutic options that will help only a limited percentage of HCC patients. Cancer immunotherapy has achieved dramatic advances i...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zhuoyan, Liu, Xuan, Liang, Jiaxin, Liu, Yixin, Hou, Xiaorui, Zhang, Meichuan, Li, Yongyin, Jiang, Xiaotao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524467/
https://www.ncbi.nlm.nih.gov/pubmed/34675942
http://dx.doi.org/10.3389/fimmu.2021.765101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524467/
https://www.ncbi.nlm.nih.gov/pubmed/34675942
http://dx.doi.org/10.3389/fimmu.2021.765101

Ejemplares similares